SIRT5-Related Desuccinylation Modification Contributes To Quercetin-Induced Protection Against Heart Failure And High-Glucose-Prompted Cardiomyocytes Injured Through Regulation Of Mitochondrial Quality Surveillance Part 2
Mar 19, 2022
Please contact oscar.xiao@wecistanche.com for more information
3.6. Quercetin Reduces High-Glucose-Induced HL-1 Inflammation Injury by Regulating Mitochondrial Quality Surveillance.
Mitochondria can alter their shape and size through quality surveillance mechanisms and generate new mitochondria through biosynthesis; thus, the mitochondrial pool is supplemented and the energy metabolism that needs

FIGURE 4:Quercetin(Que)reduces high-glucose-(HG-)induced HL-1 inflammation injury by promoting SIRT5-related desuccinylation. (a)Immunoblotting and succinylation of IDH2. RT-PCR was used to detect (b)SIRT5 and(c) IDH2 mRNA expression. (d)IDH2 succinylation. (e-g)Activities of mitochondrial respiratory complexes I/III and IV were detected using ELISA. Mean±SD;*P<0.05.

Please click here to know more
cells under various conditions are met. Mitochondrial quality surveillance is critical for cytoprotective regulation during heart failure and myocardial fibrosis [36]. To explore the regulatory mechanism of quercetin on mitochondrial quality surveillance, we evaluated the mRNA levels of Drpl/Fill and Mfn1/Mfn2 after 24h of high-glucose stimulation. Gene expression analysis showed high-glucose stimulation upregulated Drpl and Fill and downregulated Mfnl and Mfin2 in mitochondria (Figures 6(a)-6(d)); moreover, quercetin reversed these effects (Figures 6(a)-6(d)). We also evaluated mitochondrial biogenesis.qPCR analysis results showed that, after high-glucose stimulation, the expression of Tfam and PGCa was severely reduced. In turn, quercetin increased the levels of Tfam and PGCla and enhanced mitochondrial biogenesis(Figures 6(e) and 6(f)). It is worth not-ing that mitochondrial fission was increased significantly following si-SIRT5 treatment, whereas mitochondrial bio-synthesis was decreased (Figures 6(e) and 6(). Thus, the ability of quercetin to regulate mitochondrial quality surveil-lance may be closely related to SIRT5.
The results showed that the protective effect of quercetin on HL-1 cells was closely related to its regulation of

FiGURE 5: Quercetin(Que)reduces high-glucose-(HG-)induced HL-1 inflammation injury by regulating mitochondrial energy metabolism and NLRP3 levels. (a)Detection of mPTP opening rate. (b-e)Mitochondrial energy metabolism detection. (f, g)Immunofluorescence detection of NLRP3 levels. Mean±SD;*P<0.05.
mitochondrial quality surveillance. Quercetin may promote the desuccinylation of IDH2 through SIRT5, thereby maintaining mitochondrial respiratory chain function and mitochondrial homeostasis, subsequently improving cell activity.
4. Discussion
Myocardial fibrosis is closely associated with heart failure and is characterized by dysregulated extracellular matrix metabolism and collagen component ratio. It is caused by oxidative stress damage and inflammation induced by heart failure [37]. Oxidative stress and inflammatory cytokines can cause mitochondrial homeostasis disorders, affect the posttranslational modification of related proteins, cause damage to the contractile function of cardiomyocytes, and induce cardiomyocyte fibrosis, leading to heart failure [38]. Hence, a better understanding regarding the role of mitochondrial function and protein posttranslational modification in myocardial fibrosis injury will provide insights into myocardial remodeling from the perspective of mitochondrial quality surveillance and oxidative stress, while also providing new strategies for improving the prognosis and treatment of heart failure. Specifically, targeted drugs for mitochondrial quality surveillance are urgently needed

FrcuRE 6:Quercetin (Que) reduces high-glucose-(HG-)induced HL-1 inflammation injury by regulating mitochondrial quality surveillance.(a-d)Expression of Drp1/Fis1 and Mfnl/Mfn2 as determined using qPCR.(e, f) Transcriptional levels of mitochondrial DNA synthesis markers PGCla and Tfam were determined using qPCR. Mean±SD;*P<0.05. [39]. In this study, we found that the level of myocardial fibrosis in the mouse myocardium and myocardial cells increased after surgery, whereas the cardiac ejection function decreased. Moreover, quercetin can regulate myocardial cell mitochondrial homeostasis after stress injury, inhibit oxidative stress damage and inflammation, maintain cardiomyocyte activity, and reduce myocardial fibrosis damage in mice with heart failure. Quercetin can also protect myocardial tissue, increase the expression of SIRT5 in cardiomyocytes, and promote IDH2 desuccinylation.
The primary cause of death in diabetic patients is a cardiovascular disease; however, the importance of heart failure in diabetic patients is not yet fully understood. Furthermore, the relationship between these two conditions is not solely at the level of comorbidities, rather an intricate relationship exists resulting in their reciprocal promotion or suppression [40]. Additionally, indicators that are reflective of insulin resistance, including glycosylated hemoglobin (HbAlc), fasting blood glucose, and insulin levels, are related to the risk of heart failure. Additionally, a series of physiological or metabolic abnormalities, including autonomic neuropathy, microcirculation dysfunction, changes in metabolism or energy, and increased accumulation of advanced glycation end products, may cause insulin resistance or cardiomyopathy in diabetic patients [41].

Cistanche can improve immunity
Moreover, heart failure can increase the risk of insulin resistance, impaired glucose tolerance, and diabetes. Long-term abnormal carbohydrate and lipid metabolism or enhanced fatty acid metabolism and increased oxygen consumption further induce dysfunction of the mitochondrial respiratory chain of cardiomyocytes, resulting in a sharp decline in mitochondrial energy metabolism, which indirectly leads to imbalanced redox homeostasis and the over-expression of inflammatory factors [42]. Specifically, diabetic cardiomyopathy is a type of diabetes complicated by vascular disease. Utilization of glucose metabolism by myocardial cells in patients with diabetes and heart failure accompanied by myocardial ischemia and hypoxia is reduced [43,44]. The results of this study also indirectly established that a high-glucose environment can indirectly lead to mitochondrial quality surveillance.
In an oxidative stress environment, the oxygen and blood supply of cardiomyocytes is significantly reduced, resulting in the production of a large amount of oxygen-free radicals and a variety of intermediate metabolites. It can also cause a metabolic imbalance in the body, damage the myocardial cell membrane, and disrupt the balance between extracellular degradation and synthesis [45,46]. The proliferation of myocardial fibroblasts leads to myocardial fibrosis, which in turn causes a large amount of intercellular collagen to be deposited and cell structure to become disordered, effectively disrupting the balance between various types of collagen. Hence, severe myocardial fibrosis has been shown to ultimately lead to heart failure. Although most previous studies have focused on the role of quercetin in oxidative stress and inflammatory damage [47], it can also regulate mitochondrial homeostasis, the expression of related proteins, and posttranslational modifications [48]. Our results expand on these previous findings that suggest quercetin functions through SIRT5 to promote the desuccinylation of IDH2, thus regulating mitochondrial homeostasis, protecting the activity of myocardial cells, and improving the damage associated with myocardial fibrosis. Hence, quercetin may represent a new therapeutic approach for treating heart failure.
In mice, mitochondrial homeostasis disorders or dysfunctions are primarily caused by overproduction of ROS and insufficient ATP synthesis, which adversely affect the structure and function of the heart, leading to subsequent heart failure 49]. Under conditions of oxidative stress and inflammation, excessive production of ROS can cause oxidative damage to cellular proteins, lipids, and mitochondrial DNA, as well as induce cell damage and apoptosis [50]. This is largely due to the imbalance in mitochondrial homeostasis caused by the disruption of redox homeostasis associated with inflammation. Currently, many studies have indicated that the inflammatory response that occurs when heart failure occurs is closely related to oxidative stress [51]. The onset of heart failure is accompanied by severe myocardial hypertrophy and myocardial fibrosis. As far as the pathological mechanism of heart failure is concerned, when myocardial infarction occurs, factors such as myocardial ischemia, hyp-oxia, impaired mitochondrial function, and activation of neutrophils and inflammatory factors cause an explosive increase in ROS. This excess production of ROS caused by an imbalance in redox homeostasis is then accompanied by NF-xB activation and subsequent activation of proinflammatory gene promoters in monocytes. Consequently, inflammatory factor transcription is upregulated, and the NADPH oxidase complex is oxidized on the cell membrane to generate ROS, inhibiting the activity of antioxidant enzymes and further stimulating the occurrence of inflammatory reactions [52]. This vicious circle is an inducing factor for the progressive aggravation of myocardial hypertrophy and fibrosis. ROS can also damage actin and excitatory-contractile coupling proteins, resulting in cardiac muscle systolic/diastolic dysfunction. Moreover, insufficient ATP synthesis leads to a lack of energy supply to cardiomyocytes, which has serious adverse effects on cardiomyocyte survival and cardiac ejection function [53].

In addition, severe diabetic cardiomyopathy with heart failure is accompanied by myocardial hypertrophy, partial myocardial ischemia, and hypoxia [36, 53]. The energy metabolism of myocardial cells is converted from fatty acid oxidation to glycolysis to adapt to hypoxia as a self-protective mechanism. However, this conversion is accompanied by a desuccinylation modification. In this study, we found that high-glucose stimulation can lead to apoptosis or death, which may be caused by the interaction between oxidative stress and the inflammatory reaction. This reaction is also accompanied by an imbalance in mitochondrial energy metabolism and mitochondrial quality surveillance. Similar to hypoxia/ischemia, a high-glucose environment can induce excessive ROS production, resulting in oxidative stress and mitochondrial mass imbalance. Consequently, glucose metabolism disorders further aggravate the primary cardiovascular disease or microcirculation damage, which may represent a key mechanism associated with diabetes mellitus complicated with heart failure.
IDH2 participates in the tricarboxylic acid cycle by catalyzing the conversion of isocitrate to α-ketoglutarate and NADPt to NADPH. Studies have reported that the knockout of IDH2 in mice can lead to a decrease in the redox state of NADPH and thioredoxin reductase activity in mitochondria. It can also lead to decreased cell activity and mitochondrial oxygen consumption [54]. Moreover, knockout of IDH2 decreases NADPH levels and mitochondrial GPX activity in mice with hepatic ischemia-reperfusion injury, leading to mitochondrial cristae loss, mitochondrial fragmentation, mitochondrial fissure shift, cytochrome c release, and cell death [55]. A lack of IDH2 can also lead to increased mitochondrial ROS, inhibited histone deacetylase activity, and increased activation of NF-B through acetylation, leading to increases in inflammation and apoptosis [56]. Indeed, IDH2-deficient mice exhibit accelerated heart failure, increased apoptosis and hypertrophy, and mitochondrial dysfunction, which is related to an imbalance in redox homeostasis [57]. Our results are consistent with those of previous studies, indicating that mitochondrial homeostasis and quality control disorders of murine cardiomyocytes are related to the succinylation of IDH2.
Succinylation of lysine is a recently discovered protein posttranslational modification in which a lysine(K) residue in the protein is converted from the succinyl group by succinyl-coenzyme A [58, 59]. Related in vitro and in vivo studies have shown that quercetin can significantly reduce AnglI-induced myocardial contractility, fibrosis, inflammation, and myocardial hypertrophy while inhibiting the expression of fibroblast differentiation markers type I and type II collagen [28]. Quercetin also reverses isoproterenol-induced cardiac hypertrophy by restoring the cellular redox balance and protecting mitochondria [38]. Our results show that quercetin promotes the desuccinylation of IDH2 through SIRT5, regulates the redox balance, maintains mitochondrial homeostasis, inhibits inflammation, protects cardiomyocytes, reduces the level of myocardial fibrosis damage, and restores heart function. These findings are consistent with those of previous studies; that is, high-glucose stimulation causes an imbalance in redox levels, causes inflammation, and activates mitochondrial quality surveillance and homeostasis, as well as the mitochondrial apoptosis pathway. In addition, we show that SIRT5 promotes IDH2 desuccinylation, increases the sensitivity of cells to oxidative stress, and reduces oxidative stress damage to cardiomyocytes, which have also been observed previously [60].

Our study had three main limitations. First, although we conducted in vivo studies using animal models of heart failure and myocardial fibrosis to verify the regulatory effect of quercetin, we did not conduct targeted verification using gene knockout animals. Second, only mitochondrial homeostasis, and not endoplasmic reticulum function, was evaluated. The pathological mechanism of myocardial fibrosis is primarily related to calcium homeostasis. The endoplasmic reticulum is an important intracellular calcium store. Excessive or low calcium levels in the endoplasmic reticulum can cause calcium signaling disorders, leading to abnormal physiological functions in cardiomyocytes and the occurrence of myocardial fibrosis. Third, the interaction between endoplasmic reticulum stress and mitochondrial homeostasis has not been clearly elucidated in the pathogenesis of diabetes mellitus complicated with heart failure; however, myocardial fibrosis was not examined. Despite these limitations, our research shows that quercetin can promote the desuccinylation of IDH2 through SIRT5. Quercetin maintains the regulation of mitochondrial homeostasis and redox balance, inhibits inflammation, and reduces the apoptosis level of cardiomyocytes, as well as the level of muscle fibrosis and recovery of cardiac ejection function.
5. Conclusions
Our results provide insights into the pathological mechanism and clinical treatment of myocardial fibrosis and heart failure. Heart failure is one of the most serious cardiovascular complications in patients with diabetes; however, currently, there are few drugs that can control blood sugar and improve myocardial damage in clinical practice, and the treatment and pathological mechanisms remain unclear. In this study, it was discovered through in vivo experimental studies that quercetin can effectively improve the pathological response of heart failure in mice after TAC, improve cardiac function, inhibit the expression of inflammatory factors, and the level of myocardial fibrosis, and protect the myocardium. Furthermore, we showed that quercetin can regulate the redox balance of mouse cardiomyocytes under high-glucose conditions, inhibit the release of NLRP3 inflammasomes, regulate mitochondrial quality surveillance, maintain mitochondrial homeostasis, and inhibit the apoptosis or death of cardiomyocytes in high-glucose environments. In addition, the active ingredient quercetin as a natural medicine affects the SIRT5 regulatory mechanism by promoting desuccinylation. Quercetin can regulate the succinylation of SIRT5, which may improve the tolerance of mitochondria to oxidative stress and inflammation. We infer that quercetin, which has antioxidative stress effects, can regulate mitochondrial quality surveillance through the"inflammation-oxidative stress" pathway. Although there have been great advances in deciphering the pathological mechanism of the "inflammatory-oxidative stress-mitochondrial dysfunction" pathway, the associated crosstalk mechanism has not yet been fully elucidated. The results of this study suggest that quercetin may become a supplementary alternative drug or daily health supplement for patients with diabetes and heart failure; however, large-scale, multicenter clinical studies are needed to further verify its effectiveness and safety.
This article is extracted from Hindawi Oxidative Medicine and Cellular Longevity Volume 2021, Article ID 5876841, 17 pages https://doi.org/10.1155/2021/5876841





